Document is current
Any future updates will be listed below
-
Authors
Ashley, Sarah C.
Kachhy, Eesha
Brown, Kayla A.
Prescott, Meagan
D. Kelsey, Michelle
McGarrah, Robert W.
Pagidipati, Neha J.
Shah, Nishant P.
- License Information
-
More Information
Article History
Accepted: 25 March 2025
First Online: 21 April 2025
Declarations
:
: All authors have complied with ethical standards set forth by the scientific community and the journal.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: RWM: grant funding- Eli Lilly; consulting- Novo Nordisk, AstraZeneca, Bristol Myers Squibb, M3 Global Research, Arthrosi. NJP: grants- Amgen, Boehringer Ingelheim, Eggland’s Best, Eli Lilly, Novartis, and Novo Nordisk consulting- Bayer, Boehringer Ingelheim, CRISPR Therapeutics, Eli Lilly, Esperion, AstraZeneca, Merck, Novartis, and Novo Nordisk. NPS: grants funding: Amgen, Janssen, National Institutes of Health, Novartis, Merck and Co, Eli Lilly; consultant/advisor: Esperion, Amgen, Novartis, NewAmsterdam Pharma, Arrowhead Pharmaceuticals, Regeneron. The rest of the authors have no disclosures.
